Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Safety of the long-term use of proton pump inhibitors.

Thomson AB, Sauve MD, Kassam N, Kamitakahara H.

World J Gastroenterol. 2010 May 21;16(19):2323-30. Review.

PMID:
20480516
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Adverse events associated with long-term use of proton pump inhibitors].

Reimer C, Bytzer P.

Ugeskr Laeger. 2012 Sep 24;174(39):2289-93. Danish.

PMID:
23006222
[PubMed - indexed for MEDLINE]
3.

Perils and pitfalls of long-term effects of proton pump inhibitors.

Wilhelm SM, Rjater RG, Kale-Pradhan PB.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):443-51. doi: 10.1586/17512433.2013.811206. Review.

PMID:
23927671
[PubMed - indexed for MEDLINE]
4.

[Adverse effects of proton pump inhibitors: should we worry about long-term exposure?].

Roulet L, Vernaz N, Giostra E, Gasche Y, Desmeules J.

Rev Med Interne. 2012 Aug;33(8):439-45. doi: 10.1016/j.revmed.2011.12.011. Epub 2012 Jan 27. Review. French.

PMID:
22284952
[PubMed - indexed for MEDLINE]
5.

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.

Laine L, Ahnen D, McClain C, Solcia E, Walsh JH.

Aliment Pharmacol Ther. 2000 Jun;14(6):651-68. Review.

PMID:
10848649
[PubMed - indexed for MEDLINE]
Free Article
6.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
[PubMed - indexed for MEDLINE]
8.

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Clissold SP, Campoli-Richards DM.

Drugs. 1986 Jul;32(1):15-47. Review. Erratum in: Drugs 1986 Nov;32(5):preceding 383.

PMID:
3527658
[PubMed - indexed for MEDLINE]
9.

Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

Cheer SM, Prakash A, Faulds D, Lamb HM.

Drugs. 2003;63(1):101-33. Review.

PMID:
12487624
[PubMed - indexed for MEDLINE]
10.

Is there a dark side to long-term proton pump inhibitor therapy?

Nealis TB, Howden CW.

Am J Ther. 2008 Nov-Dec;15(6):536-42. doi: 10.1097/MJT.0b013e31817149bf. Review.

PMID:
19127138
[PubMed - indexed for MEDLINE]
11.

Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?

Eslami L, Nasseri-Moghaddam S.

Arch Iran Med. 2013 Aug;16(8):449-58. doi: 0013168/AIM.004.

PMID:
23906249
[PubMed - indexed for MEDLINE]
Free Article
12.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

PMID:
18021578
[PubMed - indexed for MEDLINE]
Free Article
13.

Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).

Pohle T, Domschke W.

Langenbecks Arch Surg. 2000 Aug;385(5):317-23. Review.

PMID:
11026702
[PubMed - indexed for MEDLINE]
14.

The use of proton pump inhibitors in children: a comprehensive review.

Gibbons TE, Gold BD.

Paediatr Drugs. 2003;5(1):25-40. Review.

PMID:
12513104
[PubMed - indexed for MEDLINE]
15.

Considerations for long-term use of proton-pump inhibitors.

Garnett WR.

Am J Health Syst Pharm. 1998 Nov 1;55(21):2268-79. Review.

PMID:
9825878
[PubMed - indexed for MEDLINE]
16.

[Risk of long-term treatment with proton pump inhibitors].

Mathieu N.

Rev Prat. 2008 Sep 15;58(13):1451-4. French.

PMID:
18924330
[PubMed - indexed for MEDLINE]
17.

Formulary management of proton pump inhibitors.

Byrne MF, Murray FE.

Pharmacoeconomics. 1999 Sep;16(3):225-46. Review.

PMID:
10558037
[PubMed - indexed for MEDLINE]
18.

Long-term acid inhibition: benefits and harms.

Tepeš B.

Dig Dis. 2011;29(5):476-81. doi: 10.1159/000331519. Epub 2011 Nov 16. Review.

PMID:
22095013
[PubMed - indexed for MEDLINE]
19.

Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.

Devault KR.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):197-205. doi: 10.1586/17474124.1.2.197. Review.

PMID:
19072410
[PubMed - indexed for MEDLINE]
20.

[New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].

de Korwin JD, Ducrotté P, Vallot T.

Presse Med. 2004 Jun 19;33(11):746-54. Review. French.

PMID:
15257232
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk